Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC
Clinical trial NCT03298022 · TERMINATED
Trial details
- NCT number
- NCT03298022
- Sponsor
- AltruBio Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-04
- Primary completion
- 2020-04-06
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.